Skip to main content

Want a detailed portfolio tracker?

Entero Therapeutics, Inc. Common Stock (ENTO) P/E (2024 - 2026)

Entero Therapeutics, Inc. Common Stock (ENTO) P/E from Jul 1, 2024 to Jul 20, 2026. The TTM Entero Therapeutics, Inc. Common Stock (ENTO) P/E is -0.26. You can export chart.

P/E

Annual P/E change of Entero Therapeutics, Inc. Common Stock (ENTO)

YearP/EChange
2026-0.26-31.33%
2025-0.38+232.83%
2024-0.11N/A

Comparison Entero Therapeutics, Inc. Common Stock (ENTO) P/E with competitors

Entero Therapeutics, Inc. Common Stock (ENTO) P/E is -0.26.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.65%
NBYStablecoin Development Corp0.00-101.64%
ENLVEnlivex Ltd0.07-128.47%
FGENFibroGen Inc0.24-191.35%
CHRSCoherus Biosciences Inc0.85-422.92%
FBIOFortress Biotech Inc0.95-461.17%
ORMPOramed Pharmaceuticals Inc1.50-672.01%
AGENAgenus Inc3.01-1245.35%
INVAInnoviva Inc3.15-1300.30%
VXRTVaxart Inc3.55-1450.90%
CRMDCorMedix Inc3.63-1480.85%
CVACCureVac N.V.4.45-1791.86%
GLPGGalapagos NV4.86-1949.11%
SRPTSarepta Therapeutics Inc4.88-1957.94%
ABEOAbeona Therapeutics Inc5.39-2150.28%
ABUSArbutus Biopharma Corp5.60-2229.48%
ZVRAZevra Therapeutics Inc5.89-2340.46%
SPROSpero Therapeutics Inc6.23-2470.31%
CGENCompugen Ltd6.31-2502.85%
RIGLRigel Pharmaceuticals6.87-2715.25%
SLXNSilexion Therapeutics Corp7.30-2876.62%
OMEROmeros Corporation9.26-3623.54%
AUPHAurinia Pharmaceuticals Inc9.58-3747.68%
PLXProtalix BioTherapeutics Inc10.89-4244.72%
ACADAcadia Pharmaceuticals Inc11.73-4563.45%
TBPHTheravance Biopharma Inc12.26-4766.53%
ADMAAdma Biologics Inc12.42-4825.90%
HRMYHarmony Biosciences Holdings Inc13.82-5359.47%
SABSSAB Biotherapeutics Inc14.14-5479.73%
NAGENiagen Bioscience Inc14.82-5739.24%
INCYIncyte Corp15.82-6121.50%
REGNRegeneron Pharmaceuticals Inc15.86-6134.47%
PBYIPuma Biotechnology Inc17.32-6689.74%
CPRXCatalyst Pharmaceuticals Inc17.44-6736.78%
EXELExelixis Inc17.54-6774.34%
TGTXTG Therapeutics Inc18.97-7317.80%
MDXGMimedx Group Inc20.55-7921.55%
XOMAXOMA Royalty Corp22.87-8805.52%
ARGXArgen X SE24.30-9347.19%
CTMXCytomX Therapeutics Inc24.82-9546.27%
XOMAOXOMA Royalty Corp25.34-9745.58%
HALOHalozyme Therapeutics Inc25.62-9851.73%
XOMAPXOMA Royalty Corp25.67-9869.39%
VRTXVertex Pharmaceuticals Inc27.99-10754.08%
RPRXRoyalty Pharma plc - Class A28.69-11017.74%
SLNOSoleno Therapeutics Inc29.02-11142.49%
ASNDAscendis Pharma A/S30.09-11549.79%
LGNDLigand Pharmaceuticals Inc - Class B37.91-14528.34%
APLSApellis Pharmaceuticals Inc39.02-14950.47%
BMRNBiomarin Pharmaceutical Inc42.21-16164.74%
KRYSKrystal Biotech Inc45.34-17356.56%
ONCBeiGene Ltd69.54-26565.32%
PHARPharming Group N.V.75.03-28652.82%
TECHBio-Techne Corp101.96-38902.76%
VCELVericel Corp109.92-41933.26%
ALNYAlnylam Pharmaceuticals Inc117.96-44994.51%
GMABGenmab140.29-53491.10%
TLXTelix Pharmaceuticals Ltd162.15-61811.24%
CORTCorcept Therapeutics Inc212.86-81108.16%